164
Participants
Start Date
June 28, 2018
Primary Completion Date
April 11, 2019
Study Completion Date
April 22, 2019
RVL-1201
RVL-1201 ophthalmic solution 0.1%
Vehicle ophthalmic solution
Vehicle placebo ophthalmic solution
South Shore Eye, Wantagh
Rochester Ophthalmological, Rochester
Seidenberg Protzko Eye, Havre de Grace
Cornerstone Eye, High Point
CEENTA, Charlotte
Coastal Research Associates, Roswell
Maitland Vision Center, Maitland
Sabal Eye Care, Longwood
Shettle Eye Research, Largo
Sarasota Retina Institute, Sarasota
West Coast Eye, Lecanto
Hernando Eye Institute, Brooksville
East Florida Eye, Stuart
Nashville vision Associates, Nashville
Mississippi Eye, Ocean Springs
Abrams Eye Center, Cleveland
Apex Eye, Cincinnati
Apex Eye, Cincinnati
Quinn, Foster & Assoc., Athens
Comprehensive Eye Care, Washington
Silverstein Eye, Kansas City
Heart of America Eye, Shawnee Mission
Kennar Eye Care, Pittsburg
R&R Research, San Antonio
Medical Center Ophthalmology Assocs - Keystone Research, San Antonio
Round Rock Eye, Austin
Texan Eye / Keystone, Austin
Lake Travis Eye, Lakeway
Barnet, Dulany Perkins, Phoenix
Pendelton Eye Center, Oceanside
Eye Research Foundation, Newport Beach
Michael Tran, Westminster
Orange County Ophthalmology, Garden Grove
North Bay Eye Associates, Petaluma
North Valley Eye, Mission Hills
Danbury Eye Physicians, Danbury
RVL Pharmaceuticals, Inc.
INDUSTRY